Search

Your search keyword '"Pal H"' showing total 31 results
Start Over Author "Pal H" Publisher elsevier b.v.
31 results on '"Pal H"'

25. OC-0542: Benign tumours among long-term childhood cancer survivors: a DCOG LATER record linkage study.

Author

Kok, J., Teepen, J., Van der Pal, H., Dolsma, W., Van Dulmen-den Broeder, E., Van den Heuvel-Eibrink, M., Loonen, J., Tissing, W., Bresters, D., Versluys, B., Neggers, S., Van der Heiden-van der Loo, M., Van Leeuwen, F., Caron, H., Oldenburger, F., Janssens, G., Maduro, J., Tersteeg, R., Van Rij, C., and Daniels, L.

Subjects
*CANCER patients, *LINKAGE (Genetics), *CANCER radiotherapy, *CANCER cell growth, *MEDICAL sciences
Published
2016
Full Text
View/download PDF

26. Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosis.

Author

Knijnenburg, S. L., Raemaekers, S., van den Berg, H., van Dijk, I. W. E. M., Lieverst, J. A., van der Pal, H. J., Jaspers, M. W. M., Caron, H. N., Kremer, L. C., and van Santen, H. M.

Subjects
*CHILDHOOD cancer, *COMPARATIVE studies, *FOLLOW-up studies (Medicine), *REGRESSION analysis, *STANDARD deviations, *CANCER radiotherapy, *DATA analysis, *DIAGNOSIS
Abstract

Background Our study aimed to evaluate final height in a cohort of Dutch childhood cancer survivors (CCS) and assess possible determinants of final height, including height at diagnosis. Patients and methods We calculated standard deviation scores (SDS) for height at initial cancer diagnosis and height in adulthood in a cohort of 573 CCS. Multivariable regression analyses were carried out to estimate the influence of different determinants on height SDS at follow-up. Results Overall, survivors had a normal height SDS at cancer diagnosis. However, at follow-up in adulthood, 8.9% had a height ≤−2 SDS. Height SDS at diagnosis was an important determinant for adult height SDS. Children treated with (higher doses of) radiotherapy showed significantly reduced final height SDS. Survivors treated with total body irradiation (TBI) and craniospinal radiation had the greatest loss in height (−1.56 and −1.37 SDS, respectively). Younger age at diagnosis contributed negatively to final height. Conclusion Height at diagnosis was an important determinant for height SDS at follow-up. Survivors treated with TBI, cranial and craniospinal irradiation should be monitored periodically for adequate linear growth, to enable treatment on time if necessary. For correct interpretation of treatment-related late effects studies in CCS, pre-treatment data should always be included. [ABSTRACT FROM PUBLISHER]

Published
2013
Full Text
View/download PDF

27. The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors.

Author

Sieswerda, E., Postma, A., van Dalen, E. C., van der Pal, H. J. H., Tissing, W. J. E., Rammeloo, L. A. J., Kok, W. E. M., van Leeuwen, F. E., Caron, H. N., and Kremer, L. C. M.

Subjects
*CHILDHOOD cancer, *DUTCH people, *FOLLOW-up studies (Medicine), *CANCER patients, *HEART abnormalities, *ECHOCARDIOGRAPHY, *GUIDELINES, *DISEASES, *THERAPEUTICS
Abstract

Background The Late Effects of Childhood Cancer task force of the Dutch Childhood Oncology Group (DCOG LATER) developed a guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors (CCS). In this paper, we present the methods, available evidence and final recommendations of our guideline. Materials and methods A multidisciplinary working group specified clinical questions that should be answered to get to recommendations for the guideline. We carried out short or extensive evidence summaries and determined methodological quality of studies and levels of evidence in order to answer all clinical questions. When evidence was lacking for CCS, we carefully extrapolated evidence from other populations. Final recommendations were based on evidence and consensus. Results There was high-level evidence for the increased risk of cardiac dysfunction in CCS and its main risk factors. Evidence was lacking regarding the prognosis, diagnosis and treatment of cardiac dysfunction in CCS. We recommended echocardiographic screening for asymptomatic cardiac dysfunction in CCS treated with cardiotoxic treatments and counseling about potential advantages and disadvantages of our screening recommendations. Conclusion The DCOG LATER guideline recommends risk-based screening for asymptomatic cardiac dysfunction in CCS, but it should be noted that recommendations are not completely supported by evidence in CCS. [ABSTRACT FROM AUTHOR]

Published
2012
Full Text
View/download PDF

30. PO-0770: Subsequent colorectal adenomas in childhood cancer survivors: a DCOG LATER record linkage study.

Author

Teepen, J., Kok, J., Van Leeuwen, F., Tissing, W., Dolsma, W., Van der Pal, H., Van Dulmen-den Broeder, E., Van den Heuvel-Eibrink, M., Loonen, J., Bresters, D., Versluys, A., Neggers, S., De Vries, A., Jaspers, M., Van den Berg, M., Caron, H., Van der Heiden-van der Loo, M., Hollema, N., Oldenburger, F., and Visser, O.

Subjects
*COLON cancer treatment, *CANCER radiotherapy, *CHILD patients, *ONCOLOGY research, *DISTRIBUTED cognition
Published
2016
Full Text
View/download PDF

31. PO-0771: Temporal changes in pediatric radiation oncology: DCOG LATER childhood cancer survivor study.

Author

Kok, J., Dolsma, W., Van Dulmen-den Broeder, E., Van den Heuvel-Eibrink, M., Loonen, J., Tissing, W., Bresters, D., Versluys, B., Van der Pal, H., Neggers, S., Hollema, N., Van der Heiden-van der Loo, M., Van Leeuwen, F., Oldenburger, F., Aleman, B., Janssens, G., Maduro, J., Tersteeg, R., Van Rij, C., and Daniels, L.

Subjects
*CANCER research, *TUMORS in children, *CANCER patients, *CANCER radiotherapy, *RADIATION doses
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results